methyl jasmonate di-bromide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl jasmonate di-bromide
• 英文别名: Methyl 2-[2-(2,3-dibromopentyl)-3-oxocyclopentyl]acetate
• 化学式: C₁₃H₂₀Br₂O₃
• 分子量: 384.108
• InChiKey: AQGZTONPFNFCGX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  甲基茉莉酸酯 在 溴 作用下， 以 四氯化碳 为溶剂， 生成 methyl jasmonate di-bromide
  参考文献：
  名称：

  [EN] JASMONATE DERIVATIVE COMPOUNDS, PHARMACEUTICALS COMPOSITIONS AND METHODS OF USE THEREOF
  [FR] COMPOSES DERIVES DE JASMONATE, COMPOSITIONS PHARMACEUTIQUES ET METHODES D'UTILISATION ASSOCIEES

  摘要：

  公开号：

  WO2005054172A3

文献信息

• Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof
  申请人：Flescher Eliezer

  公开号：US20070142474A1

  公开（公告）日：2007-06-21

  The present invention provides novel jasmonate derivative compounds, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for treatment of cancers, especially mammalian cancers.
• Jasmonate Derivative Compounds, Pharmaceuticals Compounds and Methods of Use Thereof
  申请人：FLESCHER Eliezer

  公开号：US20080319066A1

  公开（公告）日：2008-12-25

  The present invention provides novel jasmonate derivative compounds, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for treatment of cancers, especially mammalian cancers.
• US7425651B2
  申请人：——

  公开号：US7425651B2

  公开（公告）日：2008-09-16
• US7683211B2
  申请人：——

  公开号：US7683211B2

  公开（公告）日：2010-03-23
• [EN] JASMONATE DERIVATIVE COMPOUNDS, PHARMACEUTICALS COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] COMPOSES DERIVES DE JASMONATE, COMPOSITIONS PHARMACEUTIQUES ET METHODES D'UTILISATION ASSOCIEES
  申请人：UNIV RAMOT

  公开号：WO2005054172A3

  公开（公告）日：2005-07-07